ROBO3 and cancer: In contrast, Nakamura and colleagues recently reported a reduction of ROBO3 levels in invasive malignancies of the breast when compared with normal tissues and postulated a negative regulation of metastatic behaviors by Neural EGFL Like 2 (NELL2)/ROBO3-signaling [47].